ANL 0.00 No Change ▼ 0.00 (0%)
ASC 0.00 Decreased By ▼ -13.22 (-100%)
ASL 0.00 Decreased By ▼ -17.53 (-100%)
BOP 0.00 Decreased By ▼ -8.65 (-100%)
BYCO 0.00 Decreased By ▼ -7.29 (-100%)
FCCL 0.00 Decreased By ▼ -19.10 (-100%)
FFBL 0.00 No Change ▼ 0.00 (0%)
FFL 0.00 No Change ▼ 0.00 (0%)
FNEL 0.00 No Change ▼ 0.00 (0%)
GGGL 0.00 No Change ▼ 0.00 (0%)
GGL 30.00 Increased By ▲ 2.11 (7.57%)
HUMNL 6.65 Decreased By ▼ -0.13 (-1.92%)
JSCL 0.00 Decreased By ▼ -19.25 (-100%)
KAPCO 0.00 Decreased By ▼ -27.25 (-100%)
KEL 0.00 Decreased By ▼ -3.34 (-100%)
MDTL 0.00 No Change ▼ 0.00 (0%)
MLCF 34.25 Increased By ▲ 34.25 (0%)
NETSOL 0.00 No Change ▼ 0.00 (0%)
PACE 0.00 No Change ▼ 0.00 (0%)
PAEL 0.00 Decreased By ▼ -26.49 (-100%)
PIBTL 0.00 No Change ▼ 0.00 (0%)
POWER 0.00 No Change ▼ 0.00 (0%)
PRL 15.80 Increased By ▲ 15.80 (0%)
PTC 0.00 No Change ▼ 0.00 (0%)
SILK 0.00 No Change ▼ 0.00 (0%)
SNGP 0.00 No Change ▼ 0.00 (0%)
TELE 0.00 No Change ▼ 0.00 (0%)
TRG 0.00 No Change ▼ 0.00 (0%)
UNITY 0.00 Decreased By ▼ -29.35 (-100%)
WTL 0.00 No Change ▼ 0.00 (0%)
BR100 4,644 Decreased By ▼ -89.39 (-1.89%)
BR30 20,295 Decreased By ▼ -44.64 (-0.22%)
KSE100 45,348 Decreased By ▼ -196.27 (-0.43%)
KSE30 17,729 Decreased By ▼ -82.34 (-0.46%)
World

Pfizer and Brazil regulator in talks to speed up emergency vaccine approval

  • The company said it continues to regularly submit trial data to Anvisa as part of the process of seeking full authorization for the vaccine.
31 Dec 2020

BRASILIA: Pfizer Inc said in a statement on Wednesday that it had discussed in a meeting with Brazilian health regulator Anvisa how to speed up the process of applying for emergency use approval for its COVID-19 vaccine.

Pfizer said that, based on ongoing talks with the government and a planned meeting with Anvisa, it would consider whether to submit its vaccine for emergency use.

The company said it continues to regularly submit trial data to Anvisa as part of the process of seeking full authorization for the vaccine.

Comments

Comments are closed.